Application
ZNF780A Antibody (N-term) western blot analysis in 293 cell line lysates (35ug/lane).This demonstrates the ZNF780A antibody detected the ZNF780A protein (arrow).Application
ZNF780A Antibody (N-term) flow cytometric analysis of 293 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | ZNF780A Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | ZNF780A; Zinc finger protein 780A |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | ZNF780A Zinc finger protein 780A |
|---|---|
| Molecular Weight(MW) | 74531 Da |
| Function | May be involved in transcriptional regulation (By similarity) |
| Tissue Specificity | This ZNF780A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 61-91 amino acids from the N-terminal region of human ZNF780A. |
| Cellular Localization | Nucleus (Probable). |
| Entrez Gene | 284323 |
|---|---|
| Nucleotide Accession | NP_001136051.1 NP_001010880.2 NP_001136050.1 |
Application
ZNF780A Antibody (N-term) western blot analysis in 293 cell line lysates (35ug/lane).This demonstrates the ZNF780A antibody detected the ZNF780A protein (arrow).
Application
ZNF780A Antibody (N-term) flow cytometric analysis of 293 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
